Vision Loss News and Research

RSS

New treatment for neurodegenerative diseases may be found in used coffee grounds

Neurodegenerative disorders, including Alzheimer's, Parkinson's and Huntington's, affect millions of people in the United States, and the cost of caring for people who live with these conditions adds up to hundreds of billions of dollars each year.

21 Nov 2023

Researchers identify a promising new strategy for glaucoma cell replacement therapy

Glaucoma is one of the leading causes of blindness worldwide, and vision loss, due to the loss of retinal ganglion cells (RGCs), cannot currently be reversed with any treatment.

17 Nov 2023

Falk Trust awards $1.35 million to Case Western Reserve researchers for cancer and diabetic retinopathy treatments

A combined $1.35 million from the Dr. Ralph and Marian Falk Medical Research Trust was awarded to two researchers from the Case Western Reserve University School of Medicine to advance their work on finding more effective treatments-;and better options-;for two debilitating diseases.

17 Nov 2023

Experts develop equitable quality measures to improve lupus care by 2030

Leaders of a project to develop and implement equitable new quality measures for lupus care by the end of the decade will present their work at ACR Convergence 2023, the American College of Rheumatology's annual meeting.

7 Nov 2023

Three new studies show low-dose atropine can help slow myopia in children

Myopia, or nearsightedness, is at an all-time high among children in the US. Globally, half the population is expected to be nearsighted by 2050.

6 Nov 2023

Children need to be screened for vision problems as often as adults with sickle cell disease, study suggests

Sickle cell disease is a rare, inherited disorder in which the red blood cells become hard, sticky, and change shape, resembling the farm tool.

6 Nov 2023

New "pseudo cell" formulation could revolutionize treatment of vitreoretinal diseases

Researchers from the Institute of Process Engineering (IPE) of the Chinese Academy of Sciences and Beijing Chaoyang Hospital have developed a new "pseudo cell" formulation based on self-healing microcapsule-loading exosomes to treat diverse vitreoretinal diseases.

24 Oct 2023

Stanford Medicine researchers find new way to measure ocular aging

Using a technique they developed for studying eye fluid, Stanford Medicine researchers and their collaborators have found a way to measure ocular aging, opening avenues for treatment of numerous eye diseases.

19 Oct 2023

New compound could offer an alternative to injections for people suffering from eye condition

A new compound developed at the University of Illinois Chicago potentially could offer an alternative to injections for the millions of people who suffer from an eye condition that causes blindness.

3 Oct 2023

Mogrify extends Series A financing to $46 million USD

Mogrify Limited (Mogrify®), a biopharmaceutical company transforming the lives of patients through a novel class of in vivo reprogramming therapies, announced today an additional $10 million USD closing of its Series A financing.

From Mogrify 2 Oct 2023

Simple fingerprick blood test could help identify millions of people with undiagnosed diabetes

In 2019, there were almost 14 thousand diabetes-related deaths in the UK. That number looks set to rise. Britain currently has 4.3 million registered diabetics, but new analysis from London Medical Laboratory has revealed there are likely to be over one million Brits suffering from undiagnosed type 2 diabetes.

30 Sep 2023

Stem cell patch for treating macular degeneration to enter phase 2b clinical trial

A stem cell patch developed by USC researchers for patients with macular degeneration will soon be tested in a phase 2b clinical trial.

24 Aug 2023

Phase I trial shows positive results for stem cell treatment in patients with major cornea injuries

A team led by researchers from Mass Eye and Ear, a member of Mass General Brigham, reports the results of a phase I trial of a revolutionary stem cell treatment called cultivated autologous limbal epithelial cell transplantation (CALEC), which was found to be safe and well-tolerated over the short term in four patients with significant chemical burns in one eye.

18 Aug 2023

Vision problems linked to increased risk of dementia

Losing the ability to see clearly, and losing the ability to think or remember clearly, are two of the most dreaded, and preventable, health issues associated with getting older.

1 Aug 2023

Low-dose atropine eyedrops not effective in slowing myopia progression in children

A study conducted at Vanderbilt University Medical Center and 11 other hospitals and practices across the United States shows that use of low-dose atropine eyedrops, commonly used in a higher dose to treat lazy eye, was no better than a placebo at slowing myopia (nearsightedness) progression and elongation of the eye among children treated for two years.

1 Aug 2023

Penn Medicine and CHOP receive $26 million NIH grant to develop treatments for three rare genetic diseases

A Penn Medicine and Children's Hospital of Philadelphia (CHOP) team will seek to develop treatments for three rare, incurable genetic diseases with the help of a $26 million grant from the National Institutes of Health (NIH).

1 Aug 2023

MCW professor awarded $13 million NIH grant to study misplaced calcification in AMD and Alzheimer's

Francesca Marassi, PhD, professor and chair of biophysics at the Medical College of Wisconsin (MCW), has been awarded a five-year, $13 million program project grant (PPG) by the National Institutes of Health (NIH) to study misplaced calcification in the eyes and brains of patients suffering from age-related macular degeneration (AMD) and Alzheimer's disease (AD).

18 Jul 2023

Mobile app uses AI to detect eye diseases

Two students on the Master's Degree in Bioinformatics and Biostatistics at the Universitat Oberta de Catalunya (UOC) have developed a mobile app capable of detecting in a matter of seconds whether someone is suffering from glaucoma, diabetic retinopathy or cataracts, three of the world's most common causes of vision loss and blindness.

18 Jul 2023

Mount Sinai launches first-of-its-kind center for ophthalmic AI

The Icahn School of Medicine at Mount Sinai has launched the Center for Ophthalmic Artificial Intelligence and Human Health, the first of its kind in New York and one of the first in the United States.

5 Jul 2023

Repeat intraocular corticosteroid injections improve vision in people with persistent or recurrent uveitic macular edema

Repeat treatment with corticosteroid injections improved vision in people with persistent or recurrent uveitis-related macular edema better than two other therapies, according to results from a clinical trial funded by the National Eye Institute.

13 Jun 2023

Vision Loss News and Research

New treatment for neurodegenerative diseases may be found in used coffee grounds

Researchers identify a promising new strategy for glaucoma cell replacement therapy

Falk Trust awards $1.35 million to Case Western Reserve researchers for cancer and diabetic retinopathy treatments

Experts develop equitable quality measures to improve lupus care by 2030

Three new studies show low-dose atropine can help slow myopia in children

Children need to be screened for vision problems as often as adults with sickle cell disease, study suggests

New "pseudo cell" formulation could revolutionize treatment of vitreoretinal diseases

Stanford Medicine researchers find new way to measure ocular aging

New compound could offer an alternative to injections for people suffering from eye condition

Mogrify extends Series A financing to $46 million USD

Simple fingerprick blood test could help identify millions of people with undiagnosed diabetes

Stem cell patch for treating macular degeneration to enter phase 2b clinical trial

Phase I trial shows positive results for stem cell treatment in patients with major cornea injuries

Vision problems linked to increased risk of dementia

Low-dose atropine eyedrops not effective in slowing myopia progression in children

Penn Medicine and CHOP receive $26 million NIH grant to develop treatments for three rare genetic diseases

MCW professor awarded $13 million NIH grant to study misplaced calcification in AMD and Alzheimer's

Mobile app uses AI to detect eye diseases

Mount Sinai launches first-of-its-kind center for ophthalmic AI

Repeat intraocular corticosteroid injections improve vision in people with persistent or recurrent uveitic macular edema

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News